Clin Exp Otorhinolaryngol.  2020 Nov;13(4):340-360. 10.21053/ceo.2020.00409.

Guidelines for the Management of Unilateral Vocal Fold Paralysis From the Korean Society of Laryngology, Phoniatrics and Logopedics

• Korean Society of Laryngology
• Phoniatrics and Logopedics Guideline Task Force
• Ryu CH
• Kwon TK
• Kim H
• Kim HS
• Park IS
• Woo JH
• Lee SH
• Lee SW
• Lim JY
• Kim ST
• Jin SM
• Choi SH

• KMID: 2508511
• DOI: http://doi.org/10.21053/ceo.2020.00409

Abstract

The Korean Society of Laryngology, Phoniatrics and Logopedics appointed a task force to establish clinical practice guidelines for the management of unilateral vocal fold paralysis (UVFP). These guidelines cover a comprehensive range of management-related factors, including the diagnosis and treatment of UVFP, and provide in-depth information based on current, up-to-date knowledge. Detailed evidence profiles are provided for each recommendation. The CORE databases, including OVID Medline, Embase, the Cochrane Library, and KoreaMed, were searched to identify all relevant papers, using a predefined search strategy. When insufficient evidence existed, expert opinions and Delphi questionnaires were used to fill the evidence gap. The committee developed 16 evidence-based recommendations in six categories: initial evaluation (R1–4), spontaneous recovery (R5), medical treatment (R6), surgical treatment (R7–14), voice therapy (R15), and aspiration prevention (R16). The goal of these guidelines is to assist general otolaryngologists and speech-language pathologists who are primarily responsible for treating patients with UVFP. These guidelines are also intended to facilitate understanding of the condition among other health-care providers, including primary care physicians, nurses, and policy-makers.

Keyword

Functional Recovery; Guideline; Laryngeal Framework Surgery; Laryngoplasty; Voice Training; Vocal Fold Paralysis

Figure

• 

  Fig. 1. Flowchart for the management of unilateral vocal fold paralysis. EMG, electromyography; UVFP, unilateral vocal fold paralysis; GRBAS, grade, roughness, breathiness, asthenic, and strained; NHR, noise-to-harmonic ratio; CPP, cepstral peak prominence; UVFP, unilateral vocal fold paralysis.

Reference

1. Nouraei SA, Middleton SE, Butler CR, Sandhu GS. An estimation of the population incidence of adult unilateral vocal fold mobility impairment in England. Logoped Phoniatr Vocol. 2015; Jul. 40(2):93–4.

2. Jellish WS, Jensen RL, Anderson DE, Shea JF. Intraoperative electromyographic assessment of recurrent laryngeal nerve stress and pharyngeal injury during anterior cervical spine surgery with Caspar instrumentation. J Neurosurg. 1999; Oct. 91(2 Suppl):170–4.

3. Pisanu A, Porceddu G, Podda M, Cois A, Uccheddu A. Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy. J Surg Res. 2014; May. 188(1):152–61.

4. Crumley RL. Repair of the recurrent laryngeal nerve. Otolaryngol Clin North Am. 1990; Jun. 23(3):553–63.

5. Mirza N, Ruiz C, Baum ED, Staab JP. The prevalence of major psychiatric pathologies in patients with voice disorders. Ear Nose Throat J. 2003; Oct. 82(10):808–10.

6. Roy N, Merrill RM, Gray SD, Smith EM. Voice disorders in the general population: prevalence, risk factors, and occupational impact. Laryngoscope. 2005; Nov. 115(11):1988–95.

7. Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. J Voice. 1998; Dec. 12(4):540–50.

8. Stachler RJ, Francis DO, Schwartz SR, Damask CC, Digoy GP, Krouse HJ, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update). Otolaryngol Head Neck Surg. 2018; Mar. 158(1_suppl):S1–S42.

9. Rosen CA, Mau T, Remacle M, Hess M, Eckel HE, Young VN, et al. Nomenclature proposal to describe vocal fold motion impairment. Eur Arch Otorhinolaryngol. 2016; Aug. 273(8):1995–9.

10. Qaseem A, Snow V, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010; Aug. 153(3):194–9.

11. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013; Apr. 66(4):408–14.

12. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007; Feb. 7:10.

13. Rosow DE, Sulica L. Laryngoscopy of vocal fold paralysis: evaluation of consistency of clinical findings. Laryngoscope. 2010; Jul. 120(7):1376–82.

14. Belafsky PC, Postma GN, Reulbach TR, Holland BW, Koufman JA. Muscle tension dysphonia as a sign of underlying glottal insufficiency. Otolaryngol Head Neck Surg. 2002; Nov. 127(5):448–51.

15. Heuer RJ, Sataloff RT, Emerich K, Rulnick R, Baroody M, Spiegel JR, et al. Unilateral recurrent laryngeal nerve paralysis: the importance of “preoperative” voice therapy. J Voice. 1997; Mar. 11(1):88–94.

16. Miller S. Voice therapy for vocal fold paralysis. Otolaryngol Clin North Am. 2004; Feb. 37(1):105–19.

17. Rubin AD, Sataloff RT. Vocal fold paresis and paralysis. Otolaryngol Clin North Am. 2007; Oct. 40(5):1109–31.

18. Sellars C, Carding PN, Deary IJ, MacKenzie K, Wilson JA. Characterization of effective primary voice therapy for dysphonia. J Laryngol Otol. 2002; Dec. 116(12):1014–8.

19. Woodson GE. Configuration of the glottis in laryngeal paralysis. I: Clinical study. Laryngoscope. 1993; Nov. 103(11 Pt 1):1227–34.

20. Hiramatsu H, Tokashiki R, Nakamura M, Motohashi R, Yoshida T, Suzuki M. Characterization of arytenoid vertical displacement in unilateral vocal fold paralysis by three-dimensional computed tomography. Eur Arch Otorhinolaryngol. 2009; Jan. 266(1):97–104.

21. Paul BC, Rafii B, Achlatis S, Amin MR, Branski RC. Morbidity and patient perception of flexible laryngoscopy. Ann Otol Rhinol Laryngol. 2012; Nov. 121(11):708–13.

22. Grossman M. Experimentelle beitrage zur lehre von der posticuslahmung. Arch Laryngol Rhinol. 1897; (6):282–360.

23. Wagner R. Die medianstellung des stimmbandes bei Recurrenslahmung. Archiv F Pathol Anat. 1890; 120:437–9.

24. Behrman A. Evidence-based treatment of paralytic dysphonia: making sense of outcomes and efficacy data. Otolaryngol Clin North Am. 2004; Feb. 37(1):75–104.

25. Woo P. Quantification of videostrobolaryngoscopic findings: measurements of the normal glottal cycle. Laryngoscope. 1996; Mar. 106(3 Pt 2 Suppl 79):1–27.

26. Sercarz JA, Berke GS, Ming Y, Gerratt BR, Natividad M. Videostroboscopy of human vocal fold paralysis. Ann Otol Rhinol Laryngol. 1992; Jul. 101(7):567–77.

27. Wang W, Chen D, Chen S, Li D, Li M, Xia S, et al. Laryngeal reinnervation using ansa cervicalis for thyroid surgery-related unilateral vocal fold paralysis: a long-term outcome analysis of 237 cases. PLoS One. 2011; Apr. 6(4):e19128.

28. Harries ML, Morrison M. The role of stroboscopy in the management of a patient with a unilateral vocal fold paralysis. J Laryngol Otol. 1996; Feb. 110(2):141–3.

29. Baylor CR, Yorkston KM, Eadie TL, Strand EA, Duffy J. A systematic review of outcome measurement in unilateral vocal fold paralysis. J Med Speech Lang Pathol. 2006; Mar. 14(1):xxvii–lvii.

30. Bonilha HS, Focht KL, Martin-Harris B. Rater methodology for stroboscopy: a systematic review. J Voice. 2015; Jan. 29(1):101–8.

31. Uloza V, Vegiene A, Saferis V. Correlation between the basic video laryngostroboscopic parameters and multidimensional voice measurements. J Voice. 2013; Nov. 27(6):744–52.

32. Dejonckere PH, Bradley P, Clemente P, Cornut G, Crevier-Buchman L, Friedrich G, et al. A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol. 2001; Feb. 258(2):77–82.

33. Mattei A, Desuter G, Roux M, Lee BJ, Louges MA, Osipenko E, et al. International consensus (ICON) on basic voice assessment for unilateral vocal fold paralysis. Eur Ann Otorhinolaryngol Head Neck Dis. 2018; Feb. 135(1S):S11–5.

34. Desuter G, Dedry M, Schaar B, van Lith-Bijl J, van Benthem PP, Sjogren EV. Voice outcome indicators for unilateral vocal fold paralysis surgery: a review of the literature. Eur Arch Otorhinolaryngol. 2018; Feb. 275(2):459–68.

35. Walton C, Conway E, Blackshaw H, Carding P. Unilateral vocal fold paralysis: a systematic review of speech-language pathology management. J Voice. 2017; Jul. 31(4):509.

36. Walton C, Carding P, Flanagan K. Perspectives on voice treatment for unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg. 2018; Jun. 26(3):157–61.

37. Balasubramanium RK, Bhat JS, Fahim S 3rd, Raju R 3rd. Cepstral analysis of voice in unilateral adductor vocal fold palsy. J Voice. 2011; May. 25(3):326–9.

38. Heman-Ackah YD. Reliability of calculating the cepstral peak without linear regression analysis. J Voice. 2004; Jun. 18(2):203–8.

39. Lee CY, Jeong HS, Son HY. Usefulness of cepstral peak prominence (CPP) in unilateral vocal fold paralysis dysphonia evaluation. J Korean Soc Laryngol Phoniatr Logoped. 2017; Dec. 28(2):84–8.

40. MacGregor FB, Roberts DN, Howard DJ, Phelps PD. Vocal fold palsy: a re-evaluation of investigations. J Laryngol Otol. 1994; Mar. 108(3):193–6.

41. Rosenthal LH, Benninger MS, Deeb RH. Vocal fold immobility: a longitudinal analysis of etiology over 20 years. Laryngoscope. 2007; Oct. 117(10):1864–70.

42. Pretorius PM, Milford CA. Investigating the hoarse voice. BMJ. 2008; Oct. 337:a1726.

43. Robinson S, Pitkaranta A. Radiology findings in adult patients with vocal fold paralysis. Clin Radiol. 2006; Oct. 61(10):863–7.

44. Merati AL, Halum SL, Smith TL. Diagnostic testing for vocal fold paralysis: survey of practice and evidence-based medicine review. Laryngoscope. 2006; Sep. 116(9):1539–52.

45. Sataloff RT, Praneetvatakul P, Heuer RJ, Hawkshaw MJ, Heman-Ackah YD, Schneider SM, et al. Laryngeal electromyography: clinical application. J Voice. 2010; Mar. 24(2):228–34.

46. Wang CC, Chang MH, De Virgilio A, Jiang RS, Lai HC, Wang CP, et al. Laryngeal electromyography and prognosis of unilateral vocal fold paralysis: a long-term prospective study. Laryngoscope. 2015; Apr. 125(4):898–903.

47. Sulica L, Blitzer A. Electromyography and the immobile vocal fold. Otolaryngol Clin North Am. 2004; Feb. 37(1):59–74.

48. Heman-Ackah YD, Barr A. The value of laryngeal electromyography in the evaluation of laryngeal motion abnormalities. J Voice. 2006; Sep. 20(3):452–60.

49. Focquet A, Pereon Y, Segura S, Ferron C, Malard O, Espitalier F. Diagnostic and prognostic contribution of laryngeal electromyography in unilateral vocal-fold immobility in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017; Feb. 134(1):13–8.

50. Volk GF, Hagen R, Pototschnig C, Friedrich G, Nawka T, Arens C, et al. Laryngeal electromyography: a proposal for guidelines of the European Laryngological Society. Eur Arch Otorhinolaryngol. 2012; Oct. 269(10):2227–45.

51. Woo P, Isseroff TF, Parasher A, Richards A, Sivak M. Laryngeal Electromyographic findings in patients with vocal fold motion asymmetry. Laryngoscope. 2016; Aug. 126(8):E273–7.

52. Wang CC, Chang MH, Jiang RS, Lai HC, De Virgilio A, Wang CP, et al. Laryngeal electromyography-guided hyaluronic acid vocal fold injection for unilateral vocal fold paralysis: a prospective long-term follow-up outcome report. JAMA Otolaryngol Head Neck Surg. 2015; Mar. 141(3):264–71.

53. Wang CC, Chang MH, Wang CP, Liu SA. Prognostic indicators of unilateral vocal fold paralysis. Arch Otolaryngol Head Neck Surg. 2008; Apr. 134(4):380–8.

54. Munin MC, Heman-Ackah YD, Rosen CA, Sulica L, Maronian N, Mandel S, et al. Consensus statement: Using laryngeal electromyography for the diagnosis and treatment of vocal cord paralysis. Muscle Nerve. 2016; Jun. 53(6):850–5.

55. Rickert SM, Childs LF, Carey BT, Murry T, Sulica L. Laryngeal electromyography for prognosis of vocal fold palsy: a meta-analysis. Laryngoscope. 2012; Jan. 122(1):158–61.

56. Parnes SM, Satya-Murti S. Predictive value of laryngeal electromyography in patients with vocal cord paralysis of neurogenic origin. Laryngoscope. 1985; Nov. 95(11):1323–6.

57. Seddon HJ. A classification of nerve injuries. Br Med J. 1942; Aug. 2(4260):237–9.

58. Sunderland S. A classification of peripheral nerve injuries producing loss of function. Brain. 1951; Dec. 74(4):491–516.

59. Chen D, Chen S, Wang W, Zhang C, Zheng H. Spontaneous regeneration of recurrent laryngeal nerve following long-term vocal fold paralysis in humans: histologic evidence. Laryngoscope. 2011; May. 121(5):1035–9.

60. Mattsson P, Hydman J, Svensson M. Recovery of laryngeal function after intraoperative injury to the recurrent laryngeal nerve. Gland Surg. 2015; Feb. 4(1):27–35.

61. Woodson GE. Spontaneous laryngeal reinnervation after recurrent laryngeal or vagus nerve injury. Ann Otol Rhinol Laryngol. 2007; Jan. 116(1):57–65.

62. Sulica L. The natural history of idiopathic unilateral vocal fold paralysis: evidence and problems. Laryngoscope. 2008; Jul. 118(7):1303–7.

63. Husain S, Sadoughi B, Mor N, Levin AM, Sulica L. Time course of recovery of idiopathic vocal fold paralysis. Laryngoscope. 2018; Jan. 128(1):148–52.

64. Mau T, Pan HM, Childs LF. The natural history of recoverable vocal fold paralysis: implications for kinetics of reinnervation. Laryngoscope. 2017; Nov. 127(11):2585–90.

65. Cohen SM, Lee HJ, Roy N, Misono S. Pharmacologic management of voice disorders by general medicine providers and otolaryngologists. Laryngoscope. 2018; Mar. 128(3):682–9.

66. Holland NJ, Weiner GM. Recent developments in Bell’s palsy. BMJ. 2004; Sep. 329(7465):553–7.

67. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012; Mar. 146(3 Suppl):S1–35.

68. Wang LF, Lee KW, Kuo WR, Wu CW, Lu SP, Chiang FY. The efficacy of intraoperative corticosteroids in recurrent laryngeal nerve palsy after thyroid surgery. World J Surg. 2006; Mar. 30(3):299–303.

69. Cheng SP, Liu TP, Yang PS, Lee KS, Liu CL. Effect of perioperative dexamethasone on subjective voice quality after thyroidectomy: a meta-analysis and systematic review. Langenbecks Arch Surg. 2015; Dec. 400(8):929–36.

70. Benninger MS. Acyclovir for the treatment of idiopathic vocal fold paralysis. Ear Nose Throat J. 1992; May. 71(5):207–8.

71. Coleman C, Fozo M, Rubin A. Ramsay Hunt syndrome with severe dysphagia. J Voice. 2012; Jan. 26(1):e27–8.

72. Dunn NM, Katial RK, Hoyte FC. Vocal cord dysfunction: a review. Asthma Res Pract. 2015; Sep. 1:9.

73. Ichimura H, Ishikawa S, Yamamoto T, Onizuka M, Inadome Y, Noguchi M, et al. Effectiveness of steroid treatment for hoarseness caused by idiopathic fibrosing mediastinitis: report of a case. Surg Today. 2006; 36(4):382–4.

74. Kwon TK, Buckmire R. Injection laryngoplasty for management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg. 2004; Dec. 12(6):538–42.

75. Tamura E, Fukuda H, Tabata Y. Intracordal injection technique: materials and injection site. Tokai J Exp Clin Med. 2008; Sep. 33(3):119–23.

76. Verma SP, Dailey SH. Office-based injection laryngoplasty for the management of unilateral vocal fold paralysis. J Voice. 2014; May. 28(3):382–6.

77. Dahlqvist A, Garskog O, Laurent C, Hertegard S, Ambrosio L, Borzacchiello A. Viscoelasticity of rabbit vocal folds after injection augmentation. Laryngoscope. 2004; Jan. 114(1):138–42.

78. Arron ST, Neuhaus IM. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid. J Cosmet Dermatol. 2007; Sep. 6(3):167–71.

79. Hertegard S, Hallen L, Laurent C, Lindstrom E, Olofsson K, Testad P, et al. Cross-linked hyaluronan versus collagen for injection treatment of glottal insufficiency: 2-year follow-up. Acta Otolaryngol. 2004; Dec. 124(10):1208–14.

80. Molteni G, Bergamini G, Ricci-Maccarini A, Marchese C, Ghidini A, Alicandri-Ciufelli M, et al. Auto-crosslinked hyaluronan gel injections in phonosurgery. Otolaryngol Head Neck Surg. 2010; Apr. 142(4):547–53.

81. Mallur PS, Rosen CA. Vocal fold injection: review of indications, techniques, and materials for augmentation. Clin Exp Otorhinolaryngol. 2010; Dec. 3(4):177–82.

82. Kamer FM, Churukian MM. Clinical use of injectable collagen: a three-year retrospective review. Arch Otolaryngol. 1984; Feb. 110(2):93–8.

83. Bentkover SH. The biology of facial fillers. Facial Plast Surg. 2009; May. 25(2):73–85.

84. Milstein CF, Akst LM, Hicks MD, Abelson TI, Strome M. Long-term effects of micronized Alloderm injection for unilateral vocal fold paralysis. Laryngoscope. 2005; Sep. 115(9):1691–6.

85. Tan M, Woo P. Injection laryngoplasty with micronized dermis: a 10-year experience with 381 injections in 344 patients. Laryngoscope. 2010; Dec. 120(12):2460–6.

86. Chhetri DK, Jahan-Parwar B, Hart SD, Bhuta SM, Berke GS. Injection laryngoplasty with calcium hydroxylapatite gel implant in an in vivo canine model. Ann Otol Rhinol Laryngol. 2004; Apr. 113(4):259–64.

87. Rosen CA, Gartner-Schmidt J, Casiano R, Anderson TD, Johnson F, Remacle M, et al. Vocal fold augmentation with calcium hydroxylapatite: twelve-month report. Laryngoscope. 2009; May. 119(5):1033–41.

88. Carroll TL, Rosen CA. Long-term results of calcium hydroxylapatite for vocal fold augmentation. Laryngoscope. 2011; Feb. 121(2):313–9.

89. Tanna N, Zalkind D, Glade RS, Bielamowicz SA. Foreign body reaction to calcium hydroxylapatite vocal fold augmentation. Arch Otolaryngol Head Neck Surg. 2006; Dec. 132(12):1379–82.

90. Won SJ, Woo SH. Calcium hydroxylapatite pulmonary embolism after percutaneous injection laryngoplasty. Yonsei Med J. 2017; Nov. 58(6):1245–8.

91. Min JY, Hong SD, Kim K, Son YI. Long-term results of Artecoll injection laryngoplasty for patients with unilateral vocal fold motion impairment: safety and clinical efficacy. Arch Otolaryngol Head Neck Surg. 2008; May. 134(5):490–6.

92. Sulica L, Rosen CA, Postma GN, Simpson B, Amin M, Courey M, et al. Current practice in injection augmentation of the vocal folds: indications, treatment principles, techniques, and complications. Laryngoscope. 2010; Feb. 120(2):319–25.

93. Mathison CC, Villari CR, Klein AM, Johns MM 3rd. Comparison of outcomes and complications between awake and asleep injection laryngoplasty: a case-control study. Laryngoscope. 2009; Jul. 119(7):1417–23.

94. Young VN, Smith LJ, Sulica L, Krishna P, Rosen CA. Patient tolerance of awake, in-office laryngeal procedures: a multi-institutional perspective. Laryngoscope. 2012; Feb. 122(2):315–21.

95. Costello D. Change to earlier surgical interventions: contemporary management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg. 2015; Jun. 23(3):181–4.

96. Soriano RG, Pei YC, Fang TJ. In-office hyaluronate injection laryngoplasty as palliative treatment for unilateral vocal fold paralysis. ORL J Otorhinolaryngol Relat Spec. 2016; 78(4):187–92.

97. Chun BJ, Shim MR, Hwang YS, Joo YH, Park YH, Sun DI. The usefulness of the transcricothyroid injection laryngoplasty via contralateral paramedian approach. Auris Nasus Larynx. 2017; Feb. 44(1):93–7.

98. Woo SH, Son YI, Lee SH, Park JJ, Kim JP. Comparative analysis on the efficiency of the injection laryngoplasty technique using calcium hydroxyapatite (CaHA): the thyrohyoid approach versus the cricothyroid approach. J Voice. 2013; Mar. 27(2):236–41.

99. Tirado Y, Lewin JS, Hutcheson KA, Kupferman ME. Office-based injection laryngoplasty in the irradiated larynx. Laryngoscope. 2010; Apr. 120(4):703–6.

100. Graboyes EM, Bradley JP, Meyers BF, Nussenbaum B. Efficacy and safety of acute injection laryngoplasty for vocal cord paralysis following thoracic surgery. Laryngoscope. 2011; Nov. 121(11):2406–10.

101. Vila PM, Bhatt NK, Paniello RC. Early-injection laryngoplasty may lower risk of thyroplasty: a systematic review and meta-analysis. Laryngoscope. 2018; Apr. 128(4):935–40.

102. Pei YC, Fang TJ, Hsin LJ, Li HY, Wong AM. Early hyaluronate injection improves quality of life but not neural recovery in unilateral vocal fold paralysis: an open-label randomized controlled study. Restor Neurol Neurosci. 2015; 33(2):121–30.

103. Powell J, Carding P, Birdi R, Wilson JA. Injection laryngoplasty in the outpatient clinic under local anaesthetic: a case series of sixty-eight patients. Clin Otolaryngol. 2014; Aug. 39(4):224–7.

104. Rosen CA. Complications of phonosurgery: results of a national survey. Laryngoscope. 1998; Nov. 108(11 Pt 1):1697–703.

105. Mohammed H, Masterson L, Gendy S, Nassif R. Outpatient-based injection laryngoplasty for the management of unilateral vocal fold paralysis: clinical outcomes from a UK centre. Clin Otolaryngol. 2016; Aug. 41(4):341–6.

106. Anderson TD, Sataloff RT. Complications of collagen injection of the vocal fold: report of several unusual cases and review of the literature. J Voice. 2004; Sep. 18(3):392–7.

107. DeFatta RA, Chowdhury FR, Sataloff RT. Complications of injection laryngoplasty using calcium hydroxylapatite. J Voice. 2012; Sep. 26(5):614–8.

108. Alghonaim Y, Roskies M, Kost K, Young J. Evaluating the timing of injection laryngoplasty for vocal fold paralysis in an attempt to avoid future type 1 thyroplasty. J Otolaryngol Head Neck Surg. 2013; Mar. 42(1):24.

109. Fang TJ, Pei YC, Li HY, Wong AM, Chiang HC. Glottal gap as an early predictor for permanent laryngoplasty in unilateral vocal fold paralysis. Laryngoscope. 2014; Sep. 124(9):2125–30.

110. Friedman AD, Burns JA, Heaton JT, Zeitels SM. Early versus late injection medialization for unilateral vocal cord paralysis. Laryngoscope. 2010; Oct. 120(10):2042–6.

111. Halderman AA, Bryson PC, Benninger MS, Chota R. Safety and length of benefit of restylane for office-based injection medialization-a retrospective review of one institution’s experience. J Voice. 2014; Sep. 28(5):631–5.

112. Prendes BL, Yung KC, Likhterov I, Schneider SL, Al-Jurf SA, Courey MS. Long-term effects of injection laryngoplasty with a temporary agent on voice quality and vocal fold position. Laryngoscope. 2012; Oct. 122(10):2227–33.

113. Yung KC, Likhterov I, Courey MS. Effect of temporary vocal fold injection medialization on the rate of permanent medialization laryngoplasty in unilateral vocal fold paralysis patients. Laryngoscope. 2011; Oct. 121(10):2191–4.

114. Brandenburg JH, Kirkham W, Koschkee D. Vocal cord augmentation with autogenous fat. Laryngoscope. 1992; May. 102(5):495–500.

115. Kwon TK, An SY, Ahn JC, Kim KH, Sung MW. Calcium hydroxylapatite injection laryngoplasty for the treatment of presbylaryngis: long-term results. Laryngoscope. 2010; Feb. 120(2):326–9.

116. Pagano R, Morsomme D, Camby S, Lejeune L, Finck C. Long-term results of 18 fat injections in unilateral vocal fold paralysis. J Voice. 2017; Jul. 31(4):505.

117. Rosen CA, Thekdi AA. Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results. J Voice. 2004; Sep. 18(3):387–91.

118. Trask DK, Shellenberger DL, Hoffman HT. Transnasal, endoscopic vocal fold augmentation. Laryngoscope. 2005; Dec. 115(12):2262–5.

119. Szkielkowska A, Miaskiewicz B, Remacle M, Krasnodebska P, Skarzynski H. Quality of the voice after injection of hyaluronic acid into the vocal fold. Med Sci Monit. 2013; Apr. 19:276–82.

120. Andrews BT, Van Daele DJ, Karnell MP, McCulloch TM, Graham SM, Hoffman HT. Evaluation of open approach and injection laryngoplasty in revision thyroplasty procedures. Otolaryngol Head Neck Surg. 2008; Feb. 138(2):226–32.

121. Shen T, Damrose EJ, Morzaria S. A meta-analysis of voice outcome comparing calcium hydroxylapatite injection laryngoplasty to silicone thyroplasty. Otolaryngol Head Neck Surg. 2013; Feb. 148(2):197–208.

122. Siu J, Tam S, Fung K. A comparison of outcomes in interventions for unilateral vocal fold paralysis: a systematic review. Laryngoscope. 2016; Jul. 126(7):1616–24.

123. Cantillo-Banos E, Jurado-Ramos A, Gutierrez-Jodas J, Ariza-Vargas L. Vocal fold insufficiency: medialization laryngoplasty vs calcium hydroxylapatite microspheres (Radiesse Voice®). Acta Otolaryngol. 2013; Mar. 133(3):270–5.

124. Umeno H, Chitose S, Sato K, Ueda Y, Nakashima T. Long-term postoperative vocal function after thyroplasty type I and fat injection laryngoplasty. Ann Otol Rhinol Laryngol. 2012; Mar. 121(3):185–91.

125. Umeno H, Chitose S, Sato K, Nakashima T. Comparative study of framework surgery and fat injection laryngoplasty. J Laryngol Otol Suppl. 2009; 35–41.

126. Abraham MT, Gonen M, Kraus DH. Complications of type I thyroplasty and arytenoid adduction. Laryngoscope. 2001; Aug. 111(8):1322–9.

127. Kwon M, Choi SH. Transoral arytenoid adduction with minimal cervical incision. Laryngoscope. 2015; May. 125(5):1172–4.

128. Murata T, Yasuoka Y, Shimada T, Shino M, Iida H, Takahashi K, et al. A new and less invasive procedure for arytenoid adduction surgery: endoscopic-assisted arytenoid adduction surgery. Laryngoscope. 2011; Jun. 121(6):1274–80.

129. Young VN, Zullo TG, Rosen CA. Analysis of laryngeal framework surgery: 10-year follow-up to a national survey. Laryngoscope. 2010; Aug. 120(8):1602–8.

130. Kupferman ME, Acevedo J, Hutcheson KA, Lewin JS. Addressing an unmet need in oncology patients: rehabilitation of upper aerodigestive tract function. Ann Oncol. 2011; Oct. 22(10):2299–303.

131. Daniero JJ, Garrett CG, Francis DO. Framework surgery for treatment of unilateral vocal fold paralysis. Curr Otorhinolaryngol Rep. 2014; Jun. 2(2):119–30.

132. Isshiki N, Okamura H, Ishikawa T. Thyroplasty type I (lateral compression) for dysphonia due to vocal cord paralysis or atrophy. Acta Otolaryngol. 1975; Nov-Dec. 80(5-6):465–73.

133. Isshiki N, Tanabe M, Sawada M. Arytenoid adduction for unilateral vocal cord paralysis. Arch Otolaryngol. 1978; Oct. 104(10):555–8.

134. Chester MW, Stewart MG. Arytenoid adduction combined with medialization thyroplasty: an evidence-based review. Otolaryngol Head Neck Surg. 2003; Oct. 129(4):305–10.

135. Hess MM, Fleischer S. Laryngeal framework surgery: current strategies. Curr Opin Otolaryngol Head Neck Surg. 2016; Dec. 24(6):505–9.

136. Li AJ, Johns MM, Jackson-Menaldi C, Dailey S, Heman-Ackah Y, Merati A, et al. Glottic closure patterns: type I thyroplasty versus type I thyroplasty with arytenoid adduction. J Voice. 2011; May. 25(3):259–64.

137. Mortensen M, Carroll L, Woo P. Arytenoid adduction with medialization laryngoplasty versus injection or medialization laryngoplasty: the role of the arytenoidopexy. Laryngoscope. 2009; Apr. 119(4):827–31.

138. Chang J, Schneider SL, Curtis J, Langenstein J, Courey MS, Yung KC. Outcomes of medialization laryngoplasty with and without arytenoid adduction. Laryngoscope. 2017; Nov. 127(11):2591–5.

139. Kumai Y, Kodama N, Murakami D, Yumoto E. Comparison of vocal outcome following two different procedures for immediate RLN reconstruction. Eur Arch Otorhinolaryngol. 2016; Apr. 273(4):967–72.

140. Chou FF, Su CY, Jeng SF, Hsu KL, Lu KY. Neurorrhaphy of the recurrent laryngeal nerve. J Am Coll Surg. 2003; Jul. 197(1):52–7.

141. Lee SW, Park KN, Oh SK, Jung CH, Mok JO, Kim CH. Long-term efficacy of primary intraoperative recurrent laryngeal nerve reinnervation in the management of thyroidectomy-related unilateral vocal fold paralysis. Acta Otolaryngol. 2014; Nov. 134(11):1179–84.

142. Lee SW, Park KN. A long-term comparative prospective study between reinnervation and injection laryngoplasty. Laryngoscope. 2018; Aug. 128(8):1893–7.

143. Lorenz RR, Esclamado RM, Teker AM, Strome M, Scharpf J, Hicks D, et al. Ansa cervicalis-to-recurrent laryngeal nerve anastomosis for unilateral vocal fold paralysis: experience of a single institution. Ann Otol Rhinol Laryngol. 2008; Jan. 117(1):40–5.

144. Yumoto E, Sanuki T, Kumai Y. Immediate recurrent laryngeal nerve reconstruction and vocal outcome. Laryngoscope. 2006; Sep. 116(9):1657–61.

145. Aynehchi BB, McCoul ED, Sundaram K. Systematic review of laryngeal reinnervation techniques. Otolaryngol Head Neck Surg. 2010; Dec. 143(6):749–59.

146. Miyauchi A, Yokozawa T, Kobayashi K, Hirai K, Matsuzuka F, Kuma K. Opposite ansa cervicalis to recurrent laryngeal nerve anastomosis to restore phonation in patients with advanced thyroid cancer. Eur J Surg. 2001; Jul. 167(7):540–1.

147. Paniello RC. Laryngeal reinnervation. Otolaryngol Clin North Am. 2004; Feb. 37(1):161–81.

148. Crumley RL. Laryngeal synkinesis revisited. Ann Otol Rhinol Laryngol. 2000; Apr. 109(4):365–71.

149. Kelchner LN, Lee L, Stemple JC. Laryngeal function and vocal fatigue after prolonged reading in individuals with unilateral vocal fold paralysis. J Voice. 2003; Dec. 17(4):513–28.

150. Schneider B, Schickinger-Fischer B, Zumtobel M, Mancusi G, Bigenzahn W, Klepetko W, et al. Concept for diagnosis and therapy of unilateral recurrent laryngeal nerve paralysis following thoracic surgery. Thorac Cardiovasc Surg. 2003; Dec. 51(6):327–31.

151. Aronson AE. Clinical voice disorders. New York: Thieme Medical Publishers;1990.

152. Kao YC, Chen SH, Wang YT, Chu PY, Tan CT, Chang WD. Efficacy of voice therapy for patients with early unilateral adductor vocal fold paralysis. J Voice. 2017; Sep. 31(5):567–75.

153. Mattioli F, Menichetti M, Bergamini G, Molteni G, Alberici MP, Luppi MP, et al. Results of early versus intermediate or delayed voice therapy in patients with unilateral vocal fold paralysis: our experience in 171 patients. J Voice. 2015; Jul. 29(4):455–8.

154. Schindler A, Bottero A, Capaccio P, Ginocchio D, Adorni F, Ottaviani F. Vocal improvement after voice therapy in unilateral vocal fold paralysis. J Voice. 2008; Jan. 22(1):113–8.

155. Lee CY, An SY, Chang H, Son HY. Comparison of initial therapeutic effects of voice therapy and injection laryngoplasty for unilateral vocal cord paralysis patients. J Korean Soc Laryngol Phoniatr Logoped. 2017; Dec. 28(2):112–7.

156. Roy N, Gray SD, Simon M, Dove H, Corbin-Lewis K, Stemple JC. An evaluation of the effects of two treatment approaches for teachers with voice disorders: a prospective randomized clinical trial. J Speech Lang Hear Res. 2001; Apr. 44(2):286–96.

157. Sabol JW, Lee L, Stemple JC. The value of vocal function exercises in the practice regimen of singers. J Voice. 1995; Mar. 9(1):27–36.

158. Stemple JC, Lee L, D’Amico B, Pickup B. Efficacy of vocal function exercises as a method of improving voice production. J Voice. 1994; Sep. 8(3):271–8.

159. Isshiki N. Mechanical and dynamic aspects of voice production as related to voice therapy and phonosurgery. Otolaryngol Head Neck Surg. 2000; Jun. 122(6):782–93.

160. Isshiki N. Mechanical and dynamic aspects of voice production as related to voice therapy and phonosurgery. J Voice. 1998; Jun. 12(2):125–37.

161. Bailey EF, Hoit JD. Speaking and breathing in high respiratory drive. J Speech Lang Hear Res. 2002; Feb. 45(1):89–99.

162. MacLarnon AM, Hewitt GP. The evolution of human speech: the role of enhanced breathing control. Am J Phys Anthropol. 1999; Jul. 109(3):341–63.

163. Russell BA, Cerny FJ, Stathopoulos ET. Effects of varied vocal intensity on ventilation and energy expenditure in women and men. J Speech Lang Hear Res. 1998; Apr. 41(2):239–48.

164. Verdolini K, Druker DG, Palmer PM, Samawi H. Laryngeal adduction in resonant voice. J Voice. 1998; Sep. 12(3):315–27.

165. Yamaguchi H, Yotsukura Y, Sata H, Watanabe Y, Hirose H, Kobayashi N, et al. Pushing exercise program to correct glottal incompetence. J Voice. 1993; Sep. 7(3):250–6.

166. Speyer R. Effects of voice therapy: a systematic review. J Voice. 2008; Sep. 22(5):565–80.

167. Damrose EJ. Percutaneous injection laryngoplasty in the management of acute vocal fold paralysis. Laryngoscope. 2010; Aug. 120(8):1582–90.

168. Bhattacharyya N, Kotz T, Shapiro J. Dysphagia and aspiration with unilateral vocal cord immobility: incidence, characterization, and response to surgical treatment. Ann Otol Rhinol Laryngol. 2002; Aug. 111(8):672–9.

169. Carrau RL, Pou A, Eibling DE, Murry T, Ferguson BJ. Laryngeal framework surgery for the management of aspiration. Head Neck. 1999; Mar. 21(2):139–45.

170. Flint PW, Purcell LL, Cummings CW. Pathophysiology and indications for medialization thyroplasty in patients with dysphagia and aspiration. Otolaryngol Head Neck Surg. 1997; Mar. 116(3):349–54.